CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-09-07. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v0.8.
Verdict No. 2995 · Search date 2026-09-07 · Methodology v0.8

Five-minute static standing breaks every 30 minutes during a 7.5-hour day,
does it really help with Reduced same-day postprandial glucose and insulin responses in overweight adults?

30-Second Summary
C
Evidence Grade C · 54 · Safety unknown
A conditional acute signal, not evidence of durable glycemic control or complication prevention in established diabetes
Systematic adverse-event rates were unavailable. Findings in selected participants able to stand cannot be generalized to people with orthostatic, vascular, or musculoskeletal limitations.
What the
research shows
Grade C with 54 points. In 22 overweight postmenopausal women with dysglycemia, glucose iAUC fell 34% and insulin iAUC 20%, but a 60-person older-adult trial found no standing-only effect on primary insulin or glucose.
What the
ads claim
Claims that a standing desk treats diabetes, or borrowing walking effects for standing, exceed these acute experiments.
*

Useful facts when choosing a product

  • Standing was motionless for five minutes every 30 minutes, totaling 60 minutes.
  • The positive sample was not a general population with established diabetes.
  • The protocol and primary endpoint differ from verdict 2245's eight-week desk and broad cardiometabolic question.
Gap Measurement · Verdict 2995 · C 54
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Twenty-two overweight or obese postmenopausal women with dysglycemia experienced two of prolonged sitting, five-minute standing breaks every 30 minutes, and walking. A separate 60-person crossover trial compared the same standing dose with sitting and walking.

02

Why this is classified as C (54)

Public funding and one registered primary glucose benefit are strengths, constrained by inconsistency, acute surrogate outcomes, n below 200, and follow-up below 12 weeks, giving grade C with 54 points.

Counterpoint. Walking was more consistently favorable; a nonsignificant walking-versus-standing contrast does not prove equivalence.

Rejudgment record. Codex cross-check of two original trials, registries, and overlap with verdict 2245 — Separated Henson glucose and insulin iAUC from next-day null results and Yates standing-only null results, and distinguished the acute protocol from long-term desk and prevention claims

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR0Trials conflict in direction
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Lower same-day postprandial iAUC in selected overweight womenCGlucose fell 34% and insulin 20%.
Improved long-term HbA1c or diabetes complications?The acute trials did not measure these outcomes.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized acute incomplete-crossover trial22University, NIHR, and NHS supportRegistered primary postprandial glucose AUCGlucose iAUC -34%, P=.022; insulin iAUC -20%, P=.045Direct positive trial in a narrow population
Study 2Randomized acute crossover trial60UK public and university supportPrimary insulin; glucoseStanding versus sitting was null for bothImportant conflicting trial
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-09-07).

Henson J et al. Breaking Up Prolonged Sitting With Standing or Walking Attenuates the Postprandial Metabolic Response in Postmenopausal Women: A Randomized Acute Study. Diabetes Care. 2016;39(1):130-138. PMID: 26628415. DOI: 10.2337/dc15-1240. NCT02135172.
checked
Yates T et al. Metabolic Effects of Breaking Prolonged Sitting With Standing or Light Walking in Older South Asians and White Europeans: A Randomized Acute Study. J Gerontol A Biol Sci Med Sci. 2020;75(1):139-146. PMID: 30403772. PMCID: PMC6909896. DOI: 10.1093/gerona/gly252. NCT02453204.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none

Cite this verdict

Static Standing Breaks for Post-Meal Glucose—Positive and Null Trials Coexist Evidence Grade C card
[Chamgap] Static Standing Breaks for Post-Meal Glucose—Positive and Null Trials Coexist — Evidence Grade C·54. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/static-standing-breaks-postprandial-glucose-conflicting/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.